M. Rice
SanofiPoster Author Of 5 e-Posters
A2667 - Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
Presenter:
Date
05/20/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
B21 - SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES
A7086 - Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D101 - CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD